Other Improvements: Search for Diseases, Genes or Datasets with better quality, reattach comparisons to previously-conducted Meta-analyses, export differential analysis results
This release introduces significant improvements in search capabilities across the user interface. Specifically, we've enhanced pathway search functionality by enabling searches across various meta-data fields, including pathway name, description, keywords, and pathway content such as gene names. In addition, when querying for genes within the Target ID or Expression Analysis sections, users will receive results irrespective of the current filtering criteria. The Publications tab supports a comprehensive search approach, encompassing publication titles, abstracts, author surnames, and keywords. Furthermore, we've removed the constraint that previously limited the display to the top 500 publications associated with Genes or Diseases, offering a more extensive view of relevant publications
The druggability filters (Small molecules, Antibodies, Safety, and Novelty) on both the Meta-Analysis and Disease pages can now be customized to accommodate any combination of values. Furthermore, we've enhanced the functionality of Meta-Analysis, allowing users to add or reattach comparisons and modify the therapeutic area for previously conducted Meta-analyses, creating an editable copy for greater flexibility. Additionally, navigation within the Pharma.AI platform is now more seamless, with direct links to Chemistry42 and InClinico conveniently located in the upper left corner of every PandaOmics screen. Lastly, the Expression Analysis page for each Meta-Analysis now includes the option to export differential analysis results in a comma-separated text file, providing greater utility for your research needs.